Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.
Dong L, Wang Y, Zheng T, Pu Y, Ma Y, Qi X, Zhang W, Xue F, Shan Z, Liu J, Wang X, Mao C.
Stem Cell Res Ther. 2021 Jan 6;12(1):4. doi: 10.1186/s13287-020-02072-0.
PMID:33407872
Multi-Faceted Notch in Allergic Airway Inflammation.
Huang MT, Chiu CJ, Chiang BL.
Int J Mol Sci. 2019 Jul 17;20(14):3508. doi: 10.3390/ijms20143508.
PMID:31319491
Neuro-Immune Regulation in Inflammation and Airway Remodeling of Allergic Asthma.
Zhang N, Xu J, Jiang C, Lu S.
Front Immunol. 2022 Jun 16;13:894047. doi: 10.3389/fimmu.2022.894047. eCollection 2022.
PMID:35784284
Mesenchymal stem cells and allergic airway inflammation; a therapeutic approach to induce immunoregulatory responses.
Gholami M, Ghorban K, Sadeghi M, Dadmanesh M, Rouzbahani NH, Dehnavi S.
Int Immunopharmacol. 2023 Jul;120:110367. doi: 10.1016/j.intimp.2023.110367. Epub 2023 May 23.
PMID:37230032
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice.
Yoshida K, Morishima Y, Ano S, Sakurai H, Kuramoto K, Tsunoda Y, Yazaki K, Nakajima M, Sherpa MT, Matsuyama M, Kiwamoto T, Matsuno Y, Ishii Y, Hayashi A, Matsuzaka T, Shimano H, Hizawa N.